broker meets biotech, page-23

Better late than never though.

I am excited by the current strategy and redirection towards Cancer, I am just very frustrated and disappointed by the lack of any effective marketing.

Nothing will improve in that area without some Board and role changes.

Does the general market know yet if the animal trials have actually begun? I assume they may have from the recent presentation, but why wouldn't there be a specific ASX update on that particular MYC / cancer area?

Remind us ....
- what the trials are targeting
- how are they being conducted
- who is running the trials
- what would be a success
- when do they start/finish
- what would be the next step if successful